Lv6
2906 积分 2021-08-29 加入
Use of Real‐World Data and Real‐World Evidence in Rare Disease Drug Development: A Statistical Perspective
2天前
已完结
Real‐World Evidence in New Drug and Biologics License Application Approvals During Fiscal Years 2020–2022
2天前
已完结
A Meta‐Analysis of the Safety and Immunogenicity of Pharmacokinetic Similarity Studies and Comparative Clinical Studies
2天前
已完结
Human induced pluripotent stem cell-derived cardiomyocytes and their use in a cardiac organ-on-a-chip to assay electrophysiology, calcium and contractility
2天前
已完结
Considerations from the pharmaceutical industry (IQ MPS affiliate) workshop on animal microphysiological systems and 3Rs in drug development
2天前
已完结
Pediatric Developmental Drug Toxicity: Description of Juvenile Animal Studies in US FDA Prescribing Information and Assessing the Need for New Approach Methodologies
2天前
已完结
Clinical and HLA associations of fluoroquinolone induced liver injury: results from the Drug-Induced Liver Injury Network
2天前
求助中
Patient-Reported Outcomes as End Points in Heart Failure Trials
2天前
已完结
AI‐Driven Applications in Clinical Pharmacology and Translational Science: Insights From the ASCPT 2024 AI Preconference
3天前
已完结
FDA approvals in 2024: new options for patients across cancer types and therapeutic classes
3天前
已完结
皖公网安备34019202002308
